Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.



Question
Oral demeclocycline results in renal resistance to antidiuretic hormone and can be effective in treating patients with SIADH. However, it has been associated with acute kidney injury and is generally reserved for patients who have failed other therapies. It should be used with caution in patients with preexisting [...] disease.
Answer
kidney or liver

Question
Oral demeclocycline results in renal resistance to antidiuretic hormone and can be effective in treating patients with SIADH. However, it has been associated with acute kidney injury and is generally reserved for patients who have failed other therapies. It should be used with caution in patients with preexisting [...] disease.
Answer
?

Question
Oral demeclocycline results in renal resistance to antidiuretic hormone and can be effective in treating patients with SIADH. However, it has been associated with acute kidney injury and is generally reserved for patients who have failed other therapies. It should be used with caution in patients with preexisting [...] disease.
Answer
kidney or liver
If you want to change selection, open original toplevel document below and click on "Move attachment"

Parent (intermediate) annotation

Open it
can be effective in treating patients with SIADH. However, it has been associated with acute kidney injury and is generally reserved for patients who have failed other therapies. It should be used with caution in patients with preexisting <span>kidney or liver disease.<span><body><html>

Original toplevel document (pdf)

owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p3514

Summary

statusnot learnedmeasured difficulty37% [default]last interval [days]               
repetition number in this series0memorised on               scheduled repetition               
scheduled repetition interval               last repetition or drill

Details

No repetitions


Discussion

Do you want to join discussion? Click here to log in or create user.